MTOR and hepatocellular carcinoma: Western blot assay showed that in Huh-7 and HCCLM3 cells, myristicin decreased p-mTOR and p-AKT expression (Figures 8(A) and 9(A)) and significantly decreased the ratio of p-mTOR/mTOR (Figures 8(B) and 9(B)) and p-AKT/AKT (Figures 8(C) and 9(C)) in HCC cells.